AfriVax, Inc.

Company Description

AfriVax, Inc. is a U.S.A. corporation that researches, develops, and manufactures biopharmaceutical and biological products. The company's mission is to develop safe, efficacious vaccine, diagnostic and, therapeutic products to aid in the fight against global threats to human and animal health. AfriVax, Inc. mission is to make life-saving biomedical products and services easier to develop and manufacture anywhere in the world.

Leadership
Good leadership is an essential requirement for good business. Our Executive Team is supported by an experienced Board of Advisers and the leadership and expertise of our industry partners. This team allow us to lead the industry in the emerging arena of private sector global health business.

Industry Partners
Distributed manufacturing has revolutionized many industries. We work with a network of expert product and service suppliers who enable us to offer you an end-to-end solution for manufacturing a recombinant product from the lab to the marketplace.

Company Information

  • Contact Person:Mr. Eluem Blyden
  • Telephone:
  • Zip:98112
  • Province/State:Washington
  • City:Seattle
  • Operational Address:423 West 127th St Harlem Biospace, New York City, United States
  • Business Type:Manufacturer, Business Service (Transportation, fi
  • Year Established:2007
  • Number Of Employees:5 - 10 People
  • Trade Capacity:Eastern Asia : 20.00% Africa : 20.00%
  • Production Capacity:Factory Size : Below 1,000 square meters No. of Pr
  • R&D Capacity:No. of R&D Staff :5 - 10 People
  • Main Products:Biotechnology,Molecular Cloning Services, Human Biologics, Diagnostics,Translational Research,
  • Address:613 19th Ave East Suite 101
  • Main Markets:Eastern Asia, Africa, Southeast Asia, South Americ
  • Location:New York, United States
  • Website:Visit website

Product

  • C-Reactive Protein
  • Recombinant Rabies Glycoprotein G
Countries   China   India   Indonesia   Malaysia   Pakistan   Turkey   United Kingdom   United States   All Countries